Cargando…
Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics
INTRODUCTION: Activating mutation of the calcium-sensing receptor gene (CASR) reduces parathyroid hormone secretion and renal tubular reabsorption of calcium, defined as autosomal dominant hypocalcemia type 1 (ADH1). Patients with ADH1 may present with hypocalcemia-induced seizures. Calcitriol and c...
Autores principales: | Zung, Amnon, Barash, Galia, Banne, Ehud, Levine, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442457/ https://www.ncbi.nlm.nih.gov/pubmed/36812896 http://dx.doi.org/10.1159/000529833 |
Ejemplares similares
-
The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1)
por: Hannan, Fadil M., et al.
Publicado: (2015) -
Autosomal Dominant Hypocalcemia Type 1 (ADH1) Associated With Myoclonus and Intracerebral Calcifications
por: Elston, Marianne S, et al.
Publicado: (2022) -
Autosomal dominant hypocalcemia with a novel CASR mutation: a case study and literature review
por: Wu, Yingying, et al.
Publicado: (2022) -
Autosomal Dominant Hypocalcemia With Atypical Urine Findings Accompanied by Novel CaSR Gene Mutation and VitD Deficiency
por: Tsuji, Tomoya, et al.
Publicado: (2020) -
A Phase 2B, Open-Label, Dose-Ranging Study of Encaleret (CLTX-305) in Autosomal Dominant Hypocalcemia Type 1 (ADH1)
por: Gafni, Rachel Ilana, et al.
Publicado: (2021)